1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CAPLIN POINT LABORATORIES LTD.
Caplin Point Laboratories Ltd. NSE: CAPLIPOINT | BSE: 524742
Falling Comet
In 1 Starfolio Basket
Download real time
1727.00 14.40 (0.84%)
27.89% Fall from 52W High
22,074
NSE+BSE Volume

NSE 25 Feb, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Caplin Point's arm gets US FDA nod for drug treating low phosphate levels, with US sales of ~$67 mn See details

Caplin Point Labs - CAPLIPOINT - stock price prediction, stock forecast, target price, analyst ratings from 2 analysts

Caplin Point Labs has a share price target of Rs 2508, revenue growth forecast of 9.8%, and profit growth estimate of 14.9% for FY26, based on top 2 analyst calls.

Forecaster Screeners